New Article : Intensifying Downstream Processes
Cynthia A. Challener - BioPharm International, April 2022 Issue
The need to increase efficiency and productivity is driving adoption.
The biopharmaceutical industry is faced with the challenge of increasing efficiency and productivity to get needed medicines to patients more quickly and cost-effectively. Greater productivity and process efficiency are also required to increase capacities to meet rapidly growing demand for both traditional and next-generation biologics. Process intensification allows biomanufacturers to produce more product, often more quickly, using fewer raw materials and smaller equipment in less space. While there has been much focus on upstream process intensification, this approach can have significant impacts for downstream processing as well.